Vascular Endothelial Growth Factor (VEGF) and Microvessel Density in Squamous Cell Carcinomas of the Larynx: an Immunohistochemical Study

References

• Weinstat-Saslow D, Steeg PS. Angiogenesis and colo-nization in the tumor metastatic process: basic and applied advances. FASEB J 1994; 8: 401–7.
   Google Scholar
• Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032: 89–118.
   PubMed Web of Science ®Google Scholar
• Herlyn M, Malkowicz BS. Biology of disease, regula-tory pathways in tumor growth and invasion. Lab Invest 1991; 65: 262–71.
   PubMed Web of Science ®Google Scholar
• Rak JVV, St-Croix BD, Kerbel RS. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anticancer Drugs 1995; 6: 3–18.
   PubMed Web of Science ®Google Scholar
• Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S, Jurkiewiecz MJ. Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 1994; 168: 373–80.
   PubMed Web of Science ®Google Scholar
• Obermair A, Kohlberger P, Bancher-Todesca D, et al. Influence of microvessel density and vascular perme-ability factor/vascular endothelial growth factor expres-sion on prognosis in vulvar cancer. Gynecol Oncol 1996; 63: 204–9.
   Google Scholar
• Mattern J, Koomagi R, Volm M. Coexpression of VEGF and bFGF in human epidermoid lung car-cinoma is associated with increased vessel density. An-ticancer Res 1997; 17: 2249–52.
   Google Scholar
• Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res 1995; 55: 3964–8.
   Google Scholar
• Claffey KP, Robinson GS. Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metastasis Rev 1996; 15: 165–76.
   PubMed Web of Science ®Google Scholar
• Patterson C, Perrella MA, Endege WO, Yoshizumi M, Lee M, Haber E. Downregulation of vascular endothe-lial growth factor receptors by tumor necrosis factor-a in cultured human vascular endothelial cells. J Clin Invest 1996; 98: 490–6.
   PubMed Web of Science ®Google Scholar
• Hlatky L, Hahnfeldt P, Tsionu C, Coleman CN. Vascu-lar endothelial growth factor: environmental controls and effects in angiogenesis. Br J Cancer; 74 Suppl 1996; 27: S151–6.
   Google Scholar
• Fontanini G, Vignati S, Lucchi M. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial cell growth factor (VEGF) expression. Br J Cancer 1997; 75: 1295–301.
   Google Scholar
• Weniger W, Uthman A, Pammer J. Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. Lab Invest 1996; 75: 647–57.
   Google Scholar
• Sunderkötter C, Goebeler M, Schulze-Osthof K, Bhar-waj R, Sorg C. Macrophage-derived angiogenic factors. Pharmacol Ther 1991; 51: 195–216.
   Google Scholar
• Pertovara L, Kaipainen A, Mustonen T. Vascular en-dothelial cell growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 1994; 269: 6271–4.
   Google Scholar
• Houk KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992; 267: 26031–7.
   Google Scholar
• Folkman J. Clinical application of research on angiogen-esis. Seminars in Medicine of the Beth Israel Hospital. Boston 1995; 333: 1757–63.
   Google Scholar
• Millauer B, Wizigmann-Voos S, Schniirch H. High affinity binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angio-genesis. Cell 1993; 72: 835–46.
   PubMed Web of Science ®Google Scholar
• Klohs WD, Fry DW, Kraker AJ. Inhibitors of tyrosine kinase. Curr Opin Oncol 1997; 9: 562–8.
   PubMedGoogle Scholar
• Borgström P, Bourdon MA, Hillan KJ, Sriramaro P, Ferrara N. Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo. Prostate 1998; 35: 1–10.
   Google Scholar
• Toi M, Inada K, Suzuki H, Tominaga T. Tumor angiogenesis in breast cancer: its importance as a prog-nostic indicator and the association with vascular en-dothelial growth factor expression. Breast Cancer Res Treat 1995; 36: 193–204.
   PubMed Web of Science ®Google Scholar
• Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S. Vascular endothelial growth factor expression in pri-mary esophageal squamous cell carcinoma. Cancer 1997; 79: 206–13.
   Google Scholar
• Dray TG, Hardin NJ, Sofferman RA. Angiogenesis as a prognostic marker in early head and neck cancer. Ann Otol Rhinol Laryngol 1995; 104: 724–9.
   Google Scholar
• Salven P, Heikkila P, Anttonen A, Kajanti M, Joensuu H. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod Pathol 1997; 10: 1128–33.
   Google Scholar
• Murray JD, Carlson GW, McLaughlin K. Tumor angio-genesis as a prognostic factor in laryngeal cancer. Am J Surg 1997; 174: 523–6.
   Google Scholar